Biofarm 9M/2025 Turnover Up 14% YoY To RON263M.
Drug manufacturer Biofarm (stock symbol: BIO) ended the first nine months of 2025 with a turnover of RON263.2 million, up 14% against the year-earlier period, and EBITDA climbed 16% to RON109 million.
[Read the article in Ziarul Financiar]